CLINICAL_TRIALS
research
· 2026-02-20
Clinical Trial Update: Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion
Summary
ClinicalTrials.gov entry evaluating the safety and effectiveness of GENOSS PCB for long femoropopliteal artery lesions in patients undergoing peripheral vascula…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genoss Co., Ltd. | Conditions: PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease | Status: NOT_YET_RECRUITING